派博傳思國際中心

標題: Titlebook: Evidence-Based Psoriasis; Diagnosis and Treatm Tina Bhutani,Wilson Liao,Mio Nakamura Book 2018 Springer International Publishing AG, part o [打印本頁]

作者: Dangle    時間: 2025-3-21 17:56
書目名稱Evidence-Based Psoriasis影響因子(影響力)




書目名稱Evidence-Based Psoriasis影響因子(影響力)學科排名




書目名稱Evidence-Based Psoriasis網(wǎng)絡公開度




書目名稱Evidence-Based Psoriasis網(wǎng)絡公開度學科排名




書目名稱Evidence-Based Psoriasis被引頻次




書目名稱Evidence-Based Psoriasis被引頻次學科排名




書目名稱Evidence-Based Psoriasis年度引用




書目名稱Evidence-Based Psoriasis年度引用學科排名




書目名稱Evidence-Based Psoriasis讀者反饋




書目名稱Evidence-Based Psoriasis讀者反饋學科排名





作者: condone    時間: 2025-3-21 23:41
Book 2018sequential and combination therapy, and is written for practicing dermatologists, residents, and primary care physicians.. Evidence-Based Psoriasis. also includes high quality color photographs and tables for quick and easy reference..
作者: 正論    時間: 2025-3-22 04:16

作者: FUME    時間: 2025-3-22 06:05
Grundlagen und Rahmenbedingungen,ot fully understood, genetic and environmental factors have been implicated. Importantly, psoriasis is associated with a number of systemic complications and comorbidities that have a high impact on affected patients.
作者: Foregery    時間: 2025-3-22 09:58
Tim Heinemann,Christoph Herrmannnce-based concise overview of the topical treatments for psoriasis including corticosteroids, vitamin D derivatives, tazarotene, calcineurin inhibitors, anthralin, salicylic acid, coal tar, and lactic acid.
作者: consent    時間: 2025-3-22 16:43
https://doi.org/10.1007/978-3-662-11675-3h as their indications, contraindications, administration, combination therapies, relevant adverse effects, and application in special populations (pregnancy, pediatrics, and those without access to in-office treatment), will also be discussed.
作者: consent    時間: 2025-3-22 18:57

作者: arboretum    時間: 2025-3-22 22:35
Psoriasis: Overview and Diagnosis,ot fully understood, genetic and environmental factors have been implicated. Importantly, psoriasis is associated with a number of systemic complications and comorbidities that have a high impact on affected patients.
作者: 業(yè)余愛好者    時間: 2025-3-23 02:01

作者: Debark    時間: 2025-3-23 07:15
Phototherapy and Photochemotherapy,h as their indications, contraindications, administration, combination therapies, relevant adverse effects, and application in special populations (pregnancy, pediatrics, and those without access to in-office treatment), will also be discussed.
作者: Atmosphere    時間: 2025-3-23 12:21
Biologics,. Newer biologics in development are aimed at additional molecular targets including IL-23 p19, TBK1, IKK1ε, RORγt, and the combination of IL-17/TNF-α . This chapter focuses on biologics currently approved by the US FDA for treatment of psoriasis vulgaris.
作者: 事與愿違    時間: 2025-3-23 14:18
Energie-Effizienzbewertung von Geb?udentheir generally unfavorable side effect profiles, whereas, apremilast, a much newer oral therapy, has far fewer adverse effects. This chapter will review the evidence for use of each of these oral agents in the treatment of psoriasis.
作者: 不成比例    時間: 2025-3-23 19:03
Milton Burton,Günther O. Schenckaware of the limitations, important monitoring, and drug safety when selecting these novel treatments. However, even as the psoriasis treatment armamentarium continues to expand, many psoriasis patients may continue to experience recalcitrant disease.
作者: 緩解    時間: 2025-3-24 00:42
Alexander Nikuradse,Hans J. Mader safety and efficacy when combining various therapeutic agents and utilize strategies such as rotational therapy and sequential therapy when appropriate. This chapter will review various combination therapy strategies for the treatment of psoriasis.
作者: Introvert    時間: 2025-3-24 03:56

作者: 他去就結束    時間: 2025-3-24 08:11

作者: 我沒有命令    時間: 2025-3-24 13:11
Future Therapeutics in Psoriasis,aware of the limitations, important monitoring, and drug safety when selecting these novel treatments. However, even as the psoriasis treatment armamentarium continues to expand, many psoriasis patients may continue to experience recalcitrant disease.
作者: HUMID    時間: 2025-3-24 17:26
Combination Therapy, safety and efficacy when combining various therapeutic agents and utilize strategies such as rotational therapy and sequential therapy when appropriate. This chapter will review various combination therapy strategies for the treatment of psoriasis.
作者: Homocystinuria    時間: 2025-3-24 21:38
Maximizing Treatment Compliance in Psoriasis,ssurance concerning side effects are other basic strategies. In psoriasis management, it is just as important to ensure that patients adhere to the prescribed regimen as it is to choose the best treatment plan.
作者: Intersect    時間: 2025-3-25 02:57

作者: Fibroid    時間: 2025-3-25 05:51

作者: alcoholism    時間: 2025-3-25 09:24

作者: 吝嗇性    時間: 2025-3-25 13:17
Updates in Clinical Dermatologyhttp://image.papertrans.cn/e/image/317574.jpg
作者: labile    時間: 2025-3-25 17:59

作者: Chronological    時間: 2025-3-25 20:06

作者: Graves’-disease    時間: 2025-3-26 02:29
https://doi.org/10.1007/978-3-662-11675-3Currently, ultraviolet (UV)-based therapy is one of the first-line therapies for psoriasis due to its high response rate, relative low cost, and minimal generalized immunosuppression compared to other systemic therapies. This chapter will outline the basic principles of photomedicine and photochemis
作者: 酷熱    時間: 2025-3-26 05:36
Energie-Effizienzbewertung von Geb?udened to treat psoriasis include cytotoxic and immunomodulatory drugs such as methotrexate, cyclosporine, and apremilast. Another oral agent, acitretin, is a systemic retinoid that affects epidermal proliferation and differentiation as well as immunomodulation. Oral agents for psoriasis are effective a
作者: OVERT    時間: 2025-3-26 12:14

作者: 官僚統(tǒng)治    時間: 2025-3-26 14:54
Milton Burton,Günther O. Schenckcements have transformed treatment regimens for psoriasis by selectively targeting immune signaling molecules. The aim of this chapter is to review the clinical and research data surrounding these emerging treatments, ranging from those undergoing development to those already in clinical trials. The
作者: 竊喜    時間: 2025-3-26 18:00
Alexander Nikuradse,Hans J. Maderseverity of psoriasis. Using two or more therapies with varying mechanisms of action and safety profiles is often necessary to maintain adequate disease control while minimizing toxicity of treatments. Choosing a combination regimen that maximizes safety and efficacy, while at the same time consider
作者: Predigest    時間: 2025-3-27 00:37

作者: 跳脫衣舞的人    時間: 2025-3-27 04:41

作者: 變色龍    時間: 2025-3-27 06:36

作者: 失敗主義者    時間: 2025-3-27 11:46
Psoriasis: Overview and Diagnosis,s often found on the extensor surfaces. Several variants of psoriasis have also been described, including palmoplantar, pustular, erythrodermic, and guttate forms. Although psoriasis is usually diagnosed clinically, characteristic histologic findings include hyperkeratosis, parakeratosis, and acanth
作者: 相符    時間: 2025-3-27 16:13
Topical Treatments,calized mild-to-moderate disease where topical therapies serve as the mainstay of treatment. Topical therapies can provide both high efficacy as well as safety in this population. Furthermore, in patients with moderate-to-severe disease, short-term topical treatments may provide symptomatic relief,
作者: 改變立場    時間: 2025-3-27 20:50

作者: 分貝    時間: 2025-3-28 01:35

作者: Compassionate    時間: 2025-3-28 03:29

作者: 消音器    時間: 2025-3-28 08:57

作者: Bone-Scan    時間: 2025-3-28 12:42
Combination Therapy,severity of psoriasis. Using two or more therapies with varying mechanisms of action and safety profiles is often necessary to maintain adequate disease control while minimizing toxicity of treatments. Choosing a combination regimen that maximizes safety and efficacy, while at the same time consider
作者: 紅腫    時間: 2025-3-28 16:43

作者: 一瞥    時間: 2025-3-28 19:36
Problemstellung,ensinternen und der externen Kontrolle des Managements von Aktiengesellschaften ausgel?st. Als eine Ursache für Missmanagement und ausbleibenden Erfolg deutscher Aktiengesellschaften gilt regelm??ig die unzureichende überwachung des Vorstands durch den Aufsichtsrat. Strittig dabei ist, ob Defizite i




歡迎光臨 派博傳思國際中心 (http://www.pjsxioz.cn/) Powered by Discuz! X3.5
松滋市| 弋阳县| 万荣县| 海口市| 绥芬河市| 若羌县| 凤山县| 玉田县| 双辽市| 杨浦区| 宿州市| 浦江县| 桓台县| 乾安县| 土默特左旗| 北票市| 阿勒泰市| 靖远县| 洪洞县| 纳雍县| 新化县| 政和县| 永靖县| 监利县| 龙陵县| 江陵县| 乌兰察布市| 岗巴县| 监利县| 丹凤县| 广昌县| 百色市| 明水县| 红安县| 阳城县| 凤城市| 西乌珠穆沁旗| 阳江市| 定边县| 苗栗市| 阿克陶县|